Analyst Consensus
- Current Price
- 128.47 $
- Target (Low)
- 70.00 $
- Target (Mean)
- 182.75 $
- Target (High)
- 255.00 $
- Recommendation
- Buy
- Number of Analysts
- 27
Recommendation Distribution
Recommendation Distribution| Strong Buy | 1 |
|---|
| Buy | 18 |
|---|
| Hold | 11 |
|---|
| Sell | 1 |
|---|
| Strong Sell | 1 |
|---|
Key Ratios
- Net Profit Margin
- 43.7%
- Operating Margin
- 46.2%
- Gross Margin
- 84.1%
- Return on Equity (ROE)
- 32.6%
- Return on Assets (ROA)
- 14.7%
- Revenue Growth
- 84.7%
- Earnings Growth
- 325.0%
- Debt/Equity
- 2.48
- Current Ratio
- 6.91
- Beta
- 1.52
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 16, 2026 | Wolfe Research | Underperform → Peer Perform |
| Jun 5, 2026 | Rosenblatt | Buy → Buy |
| Jun 5, 2026 | Wedbush | Outperform → Outperform |
| May 21, 2026 | Rosenblatt | Buy → Buy |
| May 6, 2026 | Citigroup | Buy → Buy |
| May 6, 2026 | Argus Research | Hold → Buy |